Yoshiro Tanio

2.2k total citations · 1 hit paper
50 papers, 1.7k citations indexed

About

Yoshiro Tanio is a scholar working on Molecular Biology, Oncology and Epidemiology. According to data from OpenAlex, Yoshiro Tanio has authored 50 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 17 papers in Oncology and 10 papers in Epidemiology. Recurrent topics in Yoshiro Tanio's work include Virus-based gene therapy research (7 papers), Immune Cell Function and Interaction (7 papers) and Cancer Research and Treatments (6 papers). Yoshiro Tanio is often cited by papers focused on Virus-based gene therapy research (7 papers), Immune Cell Function and Interaction (7 papers) and Cancer Research and Treatments (6 papers). Yoshiro Tanio collaborates with scholars based in Japan, United States and India. Yoshiro Tanio's co-authors include Junpei Takashima, Manabu Soda, Young Lim Choi, Kengo Takeuchi, Hidenori Haruta, Takahiro Nakajima, Yoshihiro Yamashita, Yasushi Yatabe, Hideki Kimura and Tetsuya Mitsudomi and has published in prestigious journals such as New England Journal of Medicine, JNCI Journal of the National Cancer Institute and Infection and Immunity.

In The Last Decade

Yoshiro Tanio

50 papers receiving 1.6k citations

Hit Papers

EML4-ALK Mutations in Lung Cancer That Confer Resistance ... 2010 2026 2015 2020 2010 250 500 750

Peers

Yoshiro Tanio
Daniel Maslyar United States
Sean G. Buchanan United States
Jack A. Roth United States
Kristine L. Skele United States
I B Kerr United Kingdom
Daniel Maslyar United States
Yoshiro Tanio
Citations per year, relative to Yoshiro Tanio Yoshiro Tanio (= 1×) peers Daniel Maslyar

Countries citing papers authored by Yoshiro Tanio

Since Specialization
Citations

This map shows the geographic impact of Yoshiro Tanio's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yoshiro Tanio with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yoshiro Tanio more than expected).

Fields of papers citing papers by Yoshiro Tanio

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yoshiro Tanio. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yoshiro Tanio. The network helps show where Yoshiro Tanio may publish in the future.

Co-authorship network of co-authors of Yoshiro Tanio

This figure shows the co-authorship network connecting the top 25 collaborators of Yoshiro Tanio. A scholar is included among the top collaborators of Yoshiro Tanio based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yoshiro Tanio. Yoshiro Tanio is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Choi, Young Lim, Manabu Soda, Yoshihiro Yamashita, et al.. (2010). EML4-ALK Mutations in Lung Cancer That Confer Resistance to ALK Inhibitors. New England Journal of Medicine. 363(18). 1734–1739. 915 indexed citations breakdown →
2.
Nakamichi, Itsuko, Tetsuya Takakuwa, Yoshiro Tanio, Keiji Iuchi, & Katsuyuki Aozasa. (2005). Pyothorax-associated lymphoma: an unusual case with both T- and B-cell genotypes. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 447(5). 888–891. 11 indexed citations
3.
Nishino, Kazumi, Tadashi Osaki, Toru Kumagai, et al.. (2001). Adenovirus-mediated gene therapy specific for small cell lung cancer cells using a Myc-Max binding motif. International Journal of Cancer. 91(6). 851–856. 16 indexed citations
4.
Fushimi, Hiroaki, Kiyoshi Kotoh, Dai Watanabe, et al.. (2000). Malignant Melanoma in the Thymus. The American Journal of Surgical Pathology. 24(9). 1305–1308. 5 indexed citations
5.
Takemoto, Y., Mitsunori Sakatani, S. Takami, et al.. (1998). Association between angiotensin II receptor gene polymorphism and serum angiotensin converting enzyme (SACE) activity in patients with sarcoidosis. Thorax. 53(6). 459–462. 34 indexed citations
6.
Fushimi, Hiroaki, Yoshiro Tanio, & Kiyoshi Kotoh. (1998). Ectopic thymoma mimicking diffuse pleural mesothelioma: A case report. Human Pathology. 29(4). 409–410. 24 indexed citations
7.
Tachibana, Isao, Masahide Mori, Yoshiro Tanio, et al.. (1996). A 100-kDa Protein Tyrosine Phosphorylation Is Concurrent with β1 Integrin-Mediated Morphological Differentiation in Neuroblastoma and Small Cell Lung Cancer Cells. Experimental Cell Research. 227(2). 230–239. 9 indexed citations
8.
Hosoe, Shigeto, Kiyonobu Ueno, Isao Tachibana, et al.. (1994). Detailed deletion mapping of the short arm of chromosome 3 in small cell and non-small cell carcinoma of the lung. Lung Cancer. 10(5-6). 297–305. 28 indexed citations
9.
Saito, Shinichi, et al.. (1994). Complementary DNA sequence encoding the major neural cell adhesion molecule isoform in a human small cell lung cancer cell line. Lung Cancer. 10(5-6). 307–318. 8 indexed citations
10.
Hosoe, S, Kiyonobu Ueno, T Osaki, et al.. (1994). A frequent deletion of chromosome 5q21 in advanced small cell and non-small cell carcinoma of the lung.. PubMed. 54(7). 1787–90. 45 indexed citations
11.
Tanio, Yoshiro, Masatoshi Watanabe, Tadashi Osaki, et al.. (1992). High Sensitivity to Peripheral Blood Lymphocytes and Low HLA‐class I Antigen Expression of Small Cell Lung Cancer Cell Lines with Diverse Chemo‐radiosensitivity. Japanese Journal of Cancer Research. 83(7). 736–745. 7 indexed citations
12.
Ikeda, Toshiyuki, Tomiya Masuno, Takeshi Ogura, et al.. (1991). Characterization and Purification of an Immunosuppressive Factor Produced by a Small Cell Lung Cancer Cell Line. Japanese Journal of Cancer Research. 82(3). 332–338. 5 indexed citations
13.
Saito, Shinichi, Ichiro Kawase, Hideki Hara, et al.. (1991). Two monoclonal antibodies against small-cell lung cancer show existence of synergism in binding. Cancer Immunology Immunotherapy. 33(3). 165–170. 7 indexed citations
14.
Tanio, Yoshiro, Ichiro Kawase, Toshiyuki Ikeda, et al.. (1990). Chemo‐radioresistance of Small Cell Lung Cancer Cell Lines Derived from Untreated Primary Tumors Obtained by Diagnostic Bronchofiberscopy. Japanese Journal of Cancer Research. 81(3). 289–297. 9 indexed citations
15.
Kawase, Ichiro, Kiyoshi Komuta, Takuma Shirasaka, et al.. (1989). Synergy of Nocardia rubra Cell Wall Skeleton and Interleukin 2 in the in vivo Induction of Murine Lymphokine‐activated Killer Cell Activity. Japanese Journal of Cancer Research. 80(11). 1089–1097. 1 indexed citations
16.
Kawase, Ichiro, Takuma Shirasaka, Toshiyuki Ikeda, et al.. (1989). Augmentation of Murine Lymphokine‐activated Killer Cell Induction by a Factor Produced by Nocardia rubra Cell Wall Skeleton‐stimulated T Cells. Japanese Journal of Cancer Research. 80(11). 1098–1105. 2 indexed citations
17.
Tanio, Yoshiro. (1984). Comparison of antimetastatic effect against Lewis lung carcinoma after intratumoral and intravenous injections of cell-wall skeleton of Propionibacterium acnes C7 in C57B6/6 mice. Cancer Science. 75. 237–244. 2 indexed citations
18.
Zbar, Berton, et al.. (1984). Selection and rejection of retrovirus-expressing tumor cells from a heterogeneous murine leukemia virus-infected cell population.. PubMed. 44(10). 4622–9. 3 indexed citations
19.
Saiki, I, et al.. (1982). Adjuvant activity of purified peptidoglycan of Listeria monocytogenes in mice and guinea pigs. Infection and Immunity. 38(1). 58–65. 24 indexed citations
20.
Azuma, Ichiro, Mikio Yamawaki, Takahiko Yoshimoto, et al.. (1979). Antitumor activity of cell-wall skeleton of Propionibacterium acnes C7 in mice and guinea pigs.. PubMed. 70(6). 737–48. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026